Updated Jul 16, 2026
Eade Katherine A. has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Katherine A. Eade is listed as a Director of Harvard Bioscience Inc. in SEC filings with the most recent filing dated July 16, 2025. Publicly available biographical information about Ms. Eade’s educational background, career history, and other board positions is not readily accessible from major public sources as of this filing.
| Role | Director |
|---|---|
| Notability | 15/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-12 | HBIO | HARVARD BIOSCIENCE INC | A — Grant or award | 16.6K | $0.00 | |
| 2025-07-16 | HBIO | HARVARD BIOSCIENCE INC | A — Grant or award | 110.0K | $0.00 |
Katherine A. Eade is listed as a Director of Harvard Bioscience Inc. in SEC filings with the most recent filing dated July 16, 2025. Publicly available biographical information about Ms. Eade’s educational background, career history, and other board positions is not readily accessible from major public sources as of this filing.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Eade Katherine A. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.